Page 184 - Genentech News Today

/PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in providing model-informed drug discovery and development (MID3) support to help...

How a small Houston biotech company and a giant California-based rival are battling over who developed what may be a revolutionary cure for asthma and allergies.

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of...

The Global Antibody Drug Conjugates (ADCS) Market is valued at USD 4.24 Billion in 2021 and is projected to attain a value of USD 13.17 Billion by 2028 at a

Comprehensive.io is using salary data to create a useful database of what you can expect to be paid for specific tech roles.

Investegate announcements from BioNTech SE, BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors

BioNTech receives exclusive licenses from DualityBio for two investigational antibody-drug conjugate assets directed against targets expressed in a broad range of human cancersCollaboration will add... | April 3, 2023

BioNTech receives exclusive licenses from DualityBio for two investigational antibody-drug conjugate assets (DB-1303 and DB-1311) directed against targets...

/PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announces that April is PFF Community Registry Recruitment Month with activities including an...

The American Diabetes Association and Genentech have partnered to reduce inequities in eye care treatment to help those with diabetes gain equal access to the care they need.